☆ 4.7 Article

LncRNA AC012360.1 facilitates growth and metastasis by regulating the miR-139-5p/LPCAT1 axis in hepatocellular carcinoma

ENVIRONMENTAL TOXICOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Gastroenterology & Hepatology

Lysophosphatidylcholine acyltransferase 1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma via the Wnt/β-catenin signaling pathway

Ling Shen et al.

Summary: This study revealed that LPCAT1 is upregulated in HCC tissues and is associated with a poor prognosis in HCC patients. LPCAT1 promotes migration and invasion of HCC cells through regulating epithelial-mesenchymal transition markers. In vivo experiments confirmed that LPCAT1 promotes pulmonary metastasis of HCC and activates the Wnt/beta-catenin signaling pathway.

ANNALS OF HEPATOLOGY (2022)

添加到收藏夹

Article Medicine, Research & Experimental

Circular RNA circZCCHC6 contributes to tumorigenesis by regulating LPCAT1 via miR-433-3p in non-small cell lung cancer

Ying Guo et al.

Summary: This study investigated the role and mechanism of circular RNA circZCCHC6 in non-small cell lung cancer (NSCLC). The study found that circZCCHC6 was upregulated in the plasma of NSCLC patients and acted as a sponge of miR-433-3p to regulate LPCAT1 expression, thereby inhibiting the growth and epithelial-mesenchymal transition (EMT) of NSCLC cells.

CLINICAL AND EXPERIMENTAL MEDICINE (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

lncRNAfunc: a knowledgebase of lncRNA function in human cancer

Mengyuan Yang et al.

Summary: This study established a comprehensive knowledge base of the functional roles of long non-coding RNAs in human cancer, including various interaction analyses and functional annotations, providing an important resource for cancer research.

NUCLEIC ACIDS RESEARCH (2022)

添加到收藏夹

Article Dermatology

LPCAT1 Promotes Cutaneous Squamous Cell Carcinoma via EGFR-Mediated Protein Kinase B/p38MAPK Signaling Pathways

Yingjian Huang et al.

Summary: This study found that LPCAT1 is upregulated in cSCC and promotes cSCC progression through the EGFR signaling pathway, suggesting that LPCAT1 may be a potential target for cSCC treatment.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)

添加到收藏夹

Article Immunology

ncRNA-Mediated High Expression of LPCAT1 Correlates with Poor Prognosis and Tumor Immune Infiltration of Liver Hepatocellular Carcinoma

Qiu Sun et al.

Summary: This study investigates the overexpression of LPCAT1 in liver hepatocellular carcinoma (LIHC) and its correlation with prognosis, immune infiltration, and immune checkpoint expression. It also predicts the upstream noncoding RNAs (ncRNAs) involved in LPCAT1 upregulation. The findings suggest that LPCAT1 may serve as a potential oncogene in LIHC and its overexpression is associated with poor prognosis and immune dysregulation.

JOURNAL OF IMMUNOLOGY RESEARCH (2022)

添加到收藏夹

Article Oncology

LPCAT1 functions as an oncogene in cervical cancer through mediating JAK2/STAT3 signaling

Fufeng Gao et al.

Summary: LPCAT1 is over-expressed in cervical cancer tissues and is closely associated with poor prognosis. Silencing of LPCAT1 inhibits proliferation, migration, and invasion of cervical cancer cells and induces apoptosis. LPCAT1 regulates cervical cancer progression through the IL-6/STAT3 signaling pathway. LPCAT1 may serve as a potential prognostic biomarker and therapeutic target for cervical cancer.

EXPERIMENTAL CELL RESEARCH (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Overexpression of LPCAT1 enhances endometrial cancer stemness and metastasis by changing lipid components and activating TGF-β/Smad2/3 signaling pathway

Tianyi Zhao et al.

Summary: The incidence of endometrial cancer is increasing and is associated with metabolic disorders. LPCAT1, as a key enzyme in phospholipid metabolism, plays a crucial role in the development of endometrial cancer. This study shows that silencing of LPCAT1 suppresses the growth of endometrial cancer, while overexpression of LPCAT1 enhances the stemness and metastasis of endometrial cancer cells. Furthermore, LPCAT1 activates the TGF-beta/Smad2/3 signaling pathway, promoting the expression of stem cell-related transcription factors and epithelial-mesenchymal transition related proteins. Additionally, the inhibitor TSI-01 can effectively inhibit LPCAT1 activity, leading to suppressed proliferation and enhanced apoptosis of endometrial cancer cells.

ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

Long non-coding RNA (lncRNA) H19 in human cancer: From proliferation and metastasis to therapy

Mehrdad Hashemi et al.

Summary: Initiation and development of cancer depend on multiple factors including gene mutations and epigenetic changes. LncRNA H19, a non-coding RNA molecule, is found to be abnormally expressed in various cancers and contributes to tumor growth, metastasis and drug resistance. It has the potential to serve as a biomarker for poor prognosis and therapy response.

PHARMACOLOGICAL RESEARCH (2022)

添加到收藏夹

Article Oncology

LncRNA CRNDE is involved in radiation resistance in hepatocellular carcinoma via modulating the SP1/PDK1 axis

Kai-Yun Chen et al.

Summary: This study validated the mechanism of lncRNA CRNDE in radiation resistance in HCC, showing that it enhances radiation resistance by promoting PDK1 transcription through binding to SP1.

NEOPLASMA (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

LPCAT1 functions as a novel prognostic molecular marker in hepatocellular carcinoma

Hongbin Zhang et al.

Summary: This study revealed that LPCAT1 was significantly overexpressed in HCC tumor tissues and correlated with various clinicopathologic parameters. LPCAT1 expression independently predicted the overall survival of patients with HCC and may be involved in the development of HCC through cell cycle regulation.

GENES & DISEASES (2022)

添加到收藏夹

Article Medicine, Research & Experimental

LncRNA NBR2 inhibits tumorigenesis by regulating autophagy in hepatocellular carcinoma

Jia-Qi Sheng et al.

Summary: Long noncoding RNA NBR2 acts as a tumor suppressor gene in hepatocellular carcinoma, inhibiting cell proliferation, invasion, and migration, as well as promoting proliferation by repressing autophagy. The study provides a novel treatment strategy for hepatocellular carcinoma.

BIOMEDICINE & PHARMACOTHERAPY (2021)

添加到收藏夹

Article Medicine, General & Internal

Hepatocellular carcinoma

Josep M. Llovet et al.

Summary: Liver cancer, particularly hepatocellular carcinoma (HCC), poses a significant global health challenge with rising incidence projected to exceed 1 million cases by 2025. Infection by hepatitis B and C viruses remains a major risk factor for HCC, while non-alcoholic steatohepatitis is emerging as a more common risk factor in Western countries. Advances in systemic therapies for HCC, including immunotherapies and targeted therapies, are expected to revolutionize the management of this disease.

NATURE REVIEWS DISEASE PRIMERS (2021)

添加到收藏夹

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

添加到收藏夹

Article Medicine, Research & Experimental

LncRNA BACE1-AS enhances the invasive and metastatic capacity of hepatocellular carcinoma cells through mediating miR-377-3p/CELF1 axis

Chunjiang Liu et al.

Summary: The study demonstrated that lncRNA BACE1-AS was upregulated in HCC, promoting invasion and metastasis of hepatocellular carcinoma cells by modulating the miR-377-3p/CELF1 axis and contributing to the EMT pathway. BACE1-AS could be a potential biomarker in HCC for future treatment.

LIFE SCIENCES (2021)

添加到收藏夹

Article Medicine, Research & Experimental

Mir-139-5p inhibits glioma cell proliferation and progression by targeting GABRA1

Lei Wang et al.

Summary: The study investigates the pathogenesis and potential molecular markers of glioma by examining the differential expression of miRNA and mRNA. Several miRNAs and mRNAs were identified as having significant impact on glioma cell behavior, with miR-139-5p/GABRA1 axis suggested as a novel therapeutic target.

JOURNAL OF TRANSLATIONAL MEDICINE (2021)

添加到收藏夹

Article Oncology

MiR-139-5p Targetedly Regulates YAF2 and Mediates the AKT/P38 MAPK Signaling Pathway to Alleviate the Metastasis of Non-Small Cell Lung Cancer Cells and Their Resistance Against Cisplatin

Yubo Yan et al.

Summary: The study revealed that miR-139-5p alleviates the metastasis of NSCLC cells and their resistance against cisplatin by regulating YAF2 and the AKT/p38 MAPK signaling pathway. There is a targeting relationship between miR-139-5p and YAF2, and both overexpression of miR-139-5p and knockdown of YAF2 can reverse the DDP resistance in NSCLC cells, suggesting a potential novel target for improving the therapeutic effect on NSCLC.

CANCER MANAGEMENT AND RESEARCH (2021)

添加到收藏夹

Article Cell Biology

Comprehensive analysis of the competing endogenous circRNA-lncRNA-miRNA-mRNA network and identification of a novel potential biomarker for hepatocellular carcinoma

Lu Zhang et al.

Summary: By analyzing RNA sequencing data, a prognostic network containing differentially expressed mRNAs, lncRNAs, and circRNAs was constructed, with validation of its accuracy in predicting HCC prognosis. Experimental results indicate that DTYMK plays a crucial role in liver cancer cell proliferation and invasion.

AGING-US (2021)

添加到收藏夹

Article Oncology

LPCAT1 overexpression promotes the progression of hepatocellular carcinoma

Rong-Quan He et al.

Summary: This study revealed that increased LPCAT1 expression correlated with poor prognosis in HCC patients and promoted HCC progression by enhancing cellular growth, migration, and metastasis. The cell cycle and chemical carcinogenesis were identified as the most enriched signaling pathways.

CANCER CELL INTERNATIONAL (2021)

添加到收藏夹

Article Oncology

LpCat1 Promotes Malignant Transformation of Hepatocellular Carcinoma Cells by Directly Suppressing STAT1

Weidan Ji et al.

Summary: The study confirmed that high expression of LpCat1 in HCC cells promoted cancer cell invasion, playing a crucial role in the progression and metastasis of HCC by interacting with STAT1.

FRONTIERS IN ONCOLOGY (2021)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Long non-coding RNA HOXA-AS3 promotes cell proliferation of oral squamous cell carcinoma through sponging microRNA miR-218-5p

Yue Zhao et al.

Summary: The study revealed that HOXA-AS3 promotes cancer cell proliferation in oral squamous cell carcinoma (OSCC) by sponging miR-218-5p, suggesting a potential diagnostic biomarker for OSCC.

BIOENGINEERED (2021)

添加到收藏夹

Review Oncology

LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer

Yue-Tao Tan et al.

Summary: The interactions between alterations in cancer-associated energy metabolism and lncRNA-mediated posttranslational modifications play a crucial role in tumor initiation and progression. A better understanding of lncRNA-mediated cancer metabolic reprogramming can help identify new strategies for cancer diagnosis and therapy.

CANCER COMMUNICATIONS (2021)

添加到收藏夹

Review Medicine, Research & Experimental

Potential regulatory role of lncRNA-miRNA-mRNA axis in osteosarcoma

Jin-yan Wang et al.

BIOMEDICINE & PHARMACOTHERAPY (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

Regulatory Mechanism of MicroRNA Expression in Cancer

Zainab Ali Syeda et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

添加到收藏夹

Review Medical Laboratory Technology

HOTAIR LncRNA: A novel oncogenic propellant in human cancer

Taruna Rajagopal et al.

CLINICA CHIMICA ACTA (2020)

添加到收藏夹

Article Biotechnology & Applied Microbiology

LncRNA PTENP1 inhibits cervical cancer progression by suppressing miR-106b

Yingrui Fan et al.

ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

The role of long noncoding RNAs in hepatocellular carcinoma

Zhao Huang et al.

MOLECULAR CANCER (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

A miR-205-LPCAT1 axis contributes to proliferation and progression in multiple cancers

Fang Liu et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)

添加到收藏夹

Review Medicine, Research & Experimental

Diagnostic, prognostic, and therapeutic significance of miR-139-5p in cancers

Neda Khalili et al.

LIFE SCIENCES (2020)

添加到收藏夹

Article Multidisciplinary Sciences

LPCAT1 enhances castration resistant prostate cancer progression via increased mRNA synthesis and PAF production

Chao Han et al.

PLOS ONE (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

LncRNAs regulate metabolism in cancer

Wenyu Lin et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)

添加到收藏夹

Article Cell Biology

MiR-139-5p, miR-940 and miR-193a-5p inhibit the growth of hepatocellular carcinoma by targeting SPOCK1

Peng Li et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)

添加到收藏夹

Article Oncology

LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway

Chunhua Wei et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)

添加到收藏夹

Review Oncology

Roles and Regulation of Long Noncoding RNAs in Hepatocellular Carcinoma

Lee Jin Lim et al.

CANCER RESEARCH (2019)

添加到收藏夹

Review Biochemistry & Molecular Biology

Extracellular-Signal Regulated Kinase: A Central Molecule Driving Epithelial-Mesenchymal Transition in Cancer

Monserrat Olea-Flores et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

添加到收藏夹

Article Biotechnology & Applied Microbiology

miR-139-5p functions as a tumor suppressor in cervical cancer by targeting TCF4 and inhibiting Wnt/beta-catenin signaling

Xia Ji et al.

ONCOTARGETS AND THERAPY (2019)

添加到收藏夹

Review Physiology

Phospholipid Remodeling in Physiology and Disease

Bo Wang et al.

ANNUAL REVIEW OF PHYSIOLOGY, VOL 81 (2019)

添加到收藏夹

Article Medicine, Research & Experimental

Downregulation of miR-139-5p promotes prostate cancer progression through regulation of SOX5

Bin Yang et al.

BIOMEDICINE & PHARMACOTHERAPY (2019)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Reconstruction and Analysis of the Differentially Expressed lncRNA-miRNA-mRNA Network Based on Competitive Endogenous RNA in Hepatocellular Carcinoma

Dan Cao et al.

CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION (2019)

添加到收藏夹

Article Oncology

Tumor-suppressor role of miR-139-5p in endometrial cancer

JinHui Liu et al.

CANCER CELL INTERNATIONAL (2018)

添加到收藏夹

Article Medical Laboratory Technology

The diagnosis and treatment of hepatocellular carcinoma

Justin Hartke et al.

SEMINARS IN DIAGNOSTIC PATHOLOGY (2017)

添加到收藏夹

Review Oncology

Long Noncoding RNA and Cancer: A New Paradigm

Arunoday Bhan et al.

CANCER RESEARCH (2017)

添加到收藏夹

Article Oncology

Molecular screening of the LPCAT1 gene in patients with retinitis pigmentosa without defined mutations in known retinitis pigmentosa genes

Juan Wu et al.

MOLECULAR MEDICINE REPORTS (2015)

添加到收藏夹

Article Cell Biology

MiR-139-5p inhibits migration and invasion of colorectal cancer by downregulating AMFR and NOTCH1

Mingxu Song et al.

PROTEIN & CELL (2014)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.